Immunicum AB (publ) erhåller särläkemedelsstatus, ODD, från FDA för ilixadencel för behandling av mjukdelssarkom, Soft Tissue Sarcoma (STS)
January 26, 2021 02:00 ET
|
Immunicum AB
Pressmeddelande 26 januari 2021 Immunicum AB (publ) erhåller särläkemedelsstatus, ODD, från FDA för ilixadencel för behandling av mjukdelssarkom, Soft Tissue Sarcoma (STS) Immunicum AB (publ;...
Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment of Soft Tissue Sarcoma (STS)
January 26, 2021 02:00 ET
|
Immunicum AB
Press Release 26 January 2021 Immunicum AB (publ) Receives FDA Orphan Drug Designation for Ilixadencel as a Treatment of Soft Tissue Sarcoma (STS) Immunicum AB (publ; IMMU.ST) announced...
Immunicum AB (publ) meddelar förändringar i styrelsen
January 21, 2021 02:00 ET
|
Immunicum AB
Pressmeddelande 21 januari 2021 Immunicum AB (publ) meddelar förändringar i styrelsen Immunicum AB (publ: IMMU.ST) tillkännager idag att Michael Oredsson har valt att avgå som styrelseordförande...
Immunicum AB (publ) Announces Transitions in Board of Directors
January 21, 2021 02:00 ET
|
Immunicum AB
Press Release 21 January 2021 Immunicum AB (publ) Announces Transitions in Board of Directors Immunicum AB (publ: IMMU.ST) today announced that Michael Oredsson has decided to resign his position...
CORRECTION – Allegro MicroSystems Announces Results for the Second Fiscal Quarter Ended September 25, 2020
November 19, 2020 14:08 ET
|
Allegro MicroSystems, Inc.
--Strong Growth and Solid Operating Results-- MANCHESTER, N.H., Nov. 19, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Allegro MicroSystems, Inc....
Allegro MicroSystems Announces Results for the Second Fiscal Quarter Ended September 25, 2020
November 19, 2020 08:00 ET
|
Allegro MicroSystems, Inc.
--Strong Growth and Solid Operating Results-- MANCHESTER, N.H., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq:ALGM), a global leader in power and...
Allegro MicroSystems Appoints Christine King to its Board of Directors
November 04, 2020 16:30 ET
|
Allegro MicroSystems, Inc.
MANCHESTER, N.H., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”), a global leader in sensing and power semiconductor technology, today announced the appointment of...
CV Sciences, Inc. Reports Second Quarter 2020 Financial Results
August 06, 2020 16:05 ET
|
CV Sciences, Inc.
SAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. to Announce Second Quarter 2020 Results on August 6, 2020
July 23, 2020 16:05 ET
|
CV Sciences, Inc.
SAN DIEGO, July 23, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
CV Sciences, Inc. Announces Plan to Adjourn Annual Meeting of Stockholders to June 16, 2020
May 20, 2020 16:30 ET
|
CV Sciences, Inc.
SAN DIEGO, May 20, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today...